Concepedia

Monette Aujay

MA

30

Publications

5.1K

Citations

24

H-Index

1998

Active since

Affiliations

AbbVie (United States)(Current)

Rice University

National Centre of Scientific Research "Demokritos"

Dana-Farber Cancer Institute

Harvard University

Monette Aujay is an author at AbbVie (United States) specializing in medicine, pharmacology, and immunology.

Top concepts

Publications per year

1998–2022

30

Publications

30

The complete genome of the hyperthermophilic bacterium Aquifex aeolicus

Gerard Deckert, Patrick V. Warren, Terry Gaasterland et al. · Nature · 1998 · 1.1K citations · Full text

, , +4

Antitumor Activity of PR-171, a Novel Irreversible Inhibitor of the Proteasome

Susan D. Demo, Christopher J. Kirk, Monette Aujay et al. · Cancer Research · 2007 · 668 citations · Full text

A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis

Tony Muchamuel, Michael Basler, Monette Aujay et al. · Nature Medicine · 2009 · 590 citations

, , +12

A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo

Laura R. Saunders, Alexander J. Bankovich, Wade Anderson et al. · Science Translational Medicine · 2015 · 560 citations

Carfilzomib can induce tumor cell death through selective inhibition of the chymotrypsin-like activity of the proteasome

Francesco Parlati, Monette Aujay, Érika Suzuki et al. · Blood · 2009 · 320 citations

Rows per page

1–5 of 30